Authors: JOQUEVIEL C MARTINO R GILARD V MALETMARTINO M CANAL P NIEMEYER U

Citation: C. Joqueviel et al., URINARY-EXCRETION OF CYCLOPHOSPHAMIDE IN HUMANS, DETERMINED BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Drug metabolism and disposition, 26(5), 1998, pp. 418-428

Authors: ARELLANO M MALETMARTINO M MARTINO R GIRES P

Citation: M. Arellano et al., THE ANTICANCER DRUG 5-FLUOROURACIL IS METABOLIZED BY THE ISOLATED-PERFUSED RAT-LIVER AND IN RATS INTO HIGHLY TOXIC FLUOROACETATE, British Journal of Cancer, 77(1), 1998, pp. 79-86

Authors: JOQUEVIEL C GILARD V MARTINO R MALETMARTINO M NIEMEYER U

Citation: C. Joqueviel et al., URINARY STABILITY OF CARBOXYCYCLOPHOSPHAMIDE AND CARBOXYIFOSFAMIDE, 2MAJOR METABOLITES OF THE ANTICANCER DRUGS CYCLOPHOSPHAMIDE AND IFOSFAMIDE, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 391-399

Authors: JOQUEVIEL C MALETMARTINO M MARTINO R

Citation: C. Joqueviel et al., A C-13 NMR-STUDY OF 2-C-13-CHLOROACETALDEHYDE, A METABOLITE OF IFOSFAMIDE AND CYCLOPHOSPHAMIDE, IN THE ISOLATED-PERFUSED RABBIT HEART MODEL- INITIAL OBSERVATIONS ON ITS CARDIOTOXICITY AND CARDIAC METABOLISM, Cellular and molecular biology, 43(5), 1997, pp. 773-782

Authors: GILARD V MARTINO R MALETMARTINO M NIEMEYER U

Citation: V. Gilard et al., STABILITY OF COMMERCIAL FORMULATIONS AND AQUEOUS-SOLUTIONS OF IFOSFAMIDE - A REPLY, Drug metabolism and disposition, 25(8), 1997, pp. 927-931

Authors: ARELLANO M MALETMARTINO M MARTINO R SPECTOR T

Citation: M. Arellano et al., 5-ETHYNYLURACIL (GW776) - EFFECTS ON THE FORMATION OF THE TOXIC CATABOLITES OF 5-FLUOROURACIL, FLUOROACETATE AND FLUOROHYDROXYPROPIONIC ACID IN THE ISOLATED-PERFUSED RAT-LIVER MODEL, British Journal of Cancer, 76(9), 1997, pp. 1170-1180